Antidepressant effect on mothers and babies creates more controversy
new YORK (Reuters Health) – babies of women treated with antidepressants during pregnancy could present a slightly slower head growth and be more likely to be born prematurely, he noted a study carried out in Holland. Even so, that no proof that these drugs, inhibitors selective reuptake of serotonin ( SSRIS), they altered the development of babies or that the observed differences end up causing effects in the long run. “The accumulated data continue to be controversial”, he said Christina Chambers, of University of California in San Diego, and did not participate in the study. “Is not simply to know if a woman took or not a “ drug. “They are all items associated with the disease than are trying to, the duration of the use of the medication and everything what that surrounds it”, asserted. In the study, infants of women with depression, but that they did not take drugs, they also showed a growth body slower than infants of women without depression. The team of Dr. Henning Tiemeier of Medical Center Erasmus, Rotterdam, studied to nearly 8,000 pregnant for a more ambitious study on the future mothers and their babies, in the conducted quarterly controls by ultrasound for assess fetal growth. Most of the participants had few symptoms of depression, while 570 was the disease but not used drugs and other 99 were taking an SSRI. In...
Read More